Literature DB >> 25557146

Irreversible electroporation of the porcine kidney: Temperature development and distribution.

Peter G K Wagstaff1, Daniel M de Bruin2, Willemien van den Bos3, Alexandre Ingels3, Martin J C van Gemert4, Patricia J Zondervan3, Rudolf M Verdaasdonk5, Krijn P van Lienden6, Ton G van Leeuwen4, Jean J M C H de la Rosette3, M Pilar Laguna Pes3.   

Abstract

OBJECTIVE: Although tissue ablation by irreversible electroporation (IRE) has been characterized as nonthermal, the application of frequent repetitive high-intensity electric pulses has the potential of substantially heating the targeted tissue and causing thermal damage. This study evaluates the risk of possible thermal damage by measuring temperature development and distribution during IRE of porcine kidney tissue.
METHODS: The animal procedures were conducted following an approved Institutional Animal Ethics Committee protocol. IRE ablation was performed in 8 porcine kidneys. Of them, 4 kidneys were treated with a 3-needle configuration and the remaining 4 with a 4-needle configuration. All IRE ablations consisted of 70 pulses with a length 90 µs. The pulse frequency was set at 90 pulses/min, and the pulse intensity at 1,500 V/cm with a spacing of 15 mm between the needles. The temperature was measured internally using 4 fiber-optic temperature probes and at the surface using a thermal camera.
RESULTS: For the 3-needle configuration, a peak temperature of 57°C (mean = 49 ± 10°C, n = 3) was measured in the core of the ablation zone and 40°C (mean = 36 ± 3°C, n = 3) at 1cm outside of the ablation zone, from a baseline temperature of 33 ± 1°C. For the 4-needle configuration, a peak temperature of 79°C (mean = 62 ± 16°C, n = 3) was measured in the core of the ablation zone and 42°C (mean = 39 ± 3°C, n = 3) at 1cm outside of the ablation zone, from a baseline of 35 ± 1°C. The thermal camera recorded the peak surface temperatures in the center of the ablation zone, reaching 31°C and 35°C for the 3- and 4-needle configuration IRE (baseline 22°C).
CONCLUSIONS: The application of repetitive high-intensity electric pulses during IRE ablation in porcine kidney causes a lethal rise in temperature within the ablation zone. Temperature monitoring should be considered when performing IRE ablation near vital structures.
Copyright © 2015 Elsevier Inc. All rights reserved.

Keywords:  Ablation; IRE; Irreversible electroporation; Kidney; Temperature; Thermal

Mesh:

Year:  2014        PMID: 25557146     DOI: 10.1016/j.urolonc.2014.11.019

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  13 in total

1.  Successful ablation of lymph nodes using irreversible electroporation (IRE) in a porcine survival model.

Authors:  Stefan Fritz; Christof M Sommer; Thomas Longerich; Clemens Kuhn-Neureuther; Boris Radeleff; Jens Werner; Thilo Hackert
Journal:  Langenbecks Arch Surg       Date:  2017-04-04       Impact factor: 3.445

Review 2.  Heating technology for malignant tumors: a review.

Authors:  H Petra Kok; Erik N K Cressman; Wim Ceelen; Christopher L Brace; Robert Ivkov; Holger Grüll; Gail Ter Haar; Peter Wust; Johannes Crezee
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

3.  MRI and CT in the follow-up after irreversible electroporation of small renal masses.

Authors:  Mara Buijs; Daniel M de Bruin; Peter Gk Wagstaff; Patricia J Zondervan; Matthijs JV Scheltema; Marc W Engelbrecht; Maria P Laguna; Krijn P van Lienden
Journal:  Diagn Interv Radiol       Date:  2021-09       Impact factor: 2.630

4.  The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.

Authors:  Peter G K Wagstaff; Daniel M de Bruin; Patricia J Zondervan; C Dilara Savci Heijink; Marc R W Engelbrecht; Otto M van Delden; Ton G van Leeuwen; Hessel Wijkstra; Jean J M C H de la Rosette; M Pilar Laguna Pes
Journal:  BMC Cancer       Date:  2015-03-22       Impact factor: 4.430

5.  Comment to: Månsson C, Nilsson A, Karlson B-M. Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed. Acta Radiologica Short Reports 2014;3(11):1-3.

Authors:  Hester J Scheffer; Jantien A Vogel; Willemien van den Bos; Martijn R Meijerink; Marc Gh Besselink; Rudolf M Verdaasdonk; John Klaessens; Cees Wm van der Geld; Martin Jc van Gemert
Journal:  Acta Radiol Open       Date:  2015-07-07

6.  Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).

Authors:  Bor Kos; Peter Voigt; Damijan Miklavcic; Michael Moche
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

7.  The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.

Authors:  W van den Bos; D M de Bruin; R R Jurhill; C D Savci-Heijink; B G Muller; I M Varkarakis; A Skolarikos; P J Zondervan; M P Laguna-Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  World J Urol       Date:  2015-08-22       Impact factor: 4.226

8.  Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).

Authors:  Mara Buijs; Krijn P van Lienden; Peter Gk Wagstaff; Matthijs Jv Scheltema; Daniel M de Bruin; Patricia J Zondervan; Otto M van Delden; Ton G van Leeuwen; Jean Jmch de la Rosette; M Pilar Laguna
Journal:  JMIR Res Protoc       Date:  2017-02-16

9.  The Influence of a Metal Stent on the Distribution of Thermal Energy during Irreversible Electroporation.

Authors:  Hester J Scheffer; Jantien A Vogel; Willemien van den Bos; Robert E Neal; Krijn P van Lienden; Marc G H Besselink; Martin J C van Gemert; Cees W M van der Geld; Martijn R Meijerink; John H Klaessens; Rudolf M Verdaasdonk
Journal:  PLoS One       Date:  2016-02-04       Impact factor: 3.240

Review 10.  Irreversible electroporation: state of the art.

Authors:  Peter Gk Wagstaff; Mara Buijs; Willemien van den Bos; Daniel M de Bruin; Patricia J Zondervan; Jean Jmch de la Rosette; M Pilar Laguna Pes
Journal:  Onco Targets Ther       Date:  2016-04-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.